Kenvue Inc. (KVUE)
NYSE • Consumer Defensive
Last close at October 30, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Kenvue Inc. keeps $11 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Kenvue’s revenue rose 3.2% to about $3.9 billion in the third fiscal quarter of 2026, with results reported October 30, 2026 coming in line with consensus on both the top and bottom line. Adjusted EPS was $0.290, up 3.6% from $0.280 a year ago, and in line with the $0.291 estimate (-0.5%), while revenue of $3.886 billion was in line with the $3.862 billion estimate (+0.6%) and up from about $3.8 billion a year ago. Profitability tracked higher alongside the sales growth, with gross profit of roughly $2.3 billion translating to a gross margin of about 60%, and operating income of about $706 million for an operating margin near 18%. Net income increased 8.0% to about $430 million, up from roughly $398 million a year ago. The quarter generated operating cash flow of about $700 million, and Kenvue paid roughly $403 million in dividends. For the next period, consensus calls for EPS of $0.280 on revenue of $3.879 billion.
About Kenvue Inc.
Kenvue Inc. (NYSE: KVUE) makes everyday consumer health and personal care products, from pain relief and allergy remedies to skin, oral, baby, and feminine care items. In the household and personal products business, it generated $15.1 billion of revenue in FY2025.
Today's Snapshot
KVUE closed 1.3% lower at 19.31. Volume was roughly three times its usual level. The FDA, the U.S. drug regulator, approved Kenvue’s men’s Rogaine hair-loss treatments.
Trading Volume
Above 10d avg 20.1M
66.3M
vs S&P 500 Today
Inline with Market
+0.07%
Updated: November 17, 2026 at 21:14 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$18.06 - $19.24Buy
- RSI (14)59.98Neutral
- Stochastic %K (14, 3, 3)78.29Neutral
- MACD Level (12, 26)0.40Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.